Amongst the 27 potentially new TE-RBPs was the muscle-specific and dilated cardiomyopathy-associated splicing regulator RBM20, whose expression correlated particularly well with the TE of 163 experimentally validated target genes (out of 561 total targets; Glass’ Δ = 7.0; Fig 2C). The gene discussed is RBM20; the disease is dilated cardiomyopathy.